Clinical Trial

Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint

Study acronym: BPCC001
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Testing the safety and efficacy of MSC from umbilical cord tissue (UC-MSC) for the treatment of cartilage damage in the knee joint
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-13; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-20
Trial Details
NCT Number NCT06981741
Lead Sponsor BIONCaRT GmbH
Collaborators: KKS Netzwerk, Fraunhofer Institute for Cell Therapy and Immunology IZI, Polski Bank Komorek Macierzystych JSC (PBKM)
Conditions Cartilage Damage
Enrollment 55 participants
Start Date 2025-11-10
Primary Completion 2027-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-13